Health Condition 1: F42- Obsessive-compulsive disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Resistant OCD patients i.e., patients showing less than 35% improvement in YBOCS score greater than 16 after receiving 6-8 weeks treatment of combination of at least 2 first line drugs in OCD including SSRIs’, CLOMIPRAMINE, in maximum tolerable recommended dosages. 2.Patient aged between 18 and 60 years 3.Patient from both gender 4.Patient/Patient’s caregivers who will give written consent for the study 5.All patients will stable on medication for about 6 weeks prior to participating in study.
Exclusion criteria
Exclusion criteria: 1.Those who do not give consent. 2.Who has history of seizures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the efficacy of low frequency rTMS (1 Hz, 110 % MT, 1200 pulses/day) over supplementary motor as an augmentation treatment in cases of pharmacoresistant OCD patients.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| to see the adverse effects of rTMS To see the changes in BDI score and QoLTimepoint: 2weeks, 4weeks | — |
Countries
India
Contacts
Jawaharlal Nehru Medical College AMU